Nasdaq
VRAX
Virax Biolabs Group Limited
- Health Care
- United Kingdom
- Listed 2022
- 1 day
- −4.8%
- 1 month
- −8.9%
- 1 year
- −85.9%
$2.77 · Mkt cap $2.21M
At the 6 Aug 2026 close
Nasdaq
Virax Biolabs Group Limited
$2.77 · Mkt cap $2.21M
At the 6 Aug 2026 close
Virax Biolabs Group Limited trades under the ticker VRAX on Nasdaq, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). It has been listed since 2022. Its market capitalisation is $2.21M. The last closing price was $2.77, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −85.9%, and −8.9% over the past month. Returns are price returns and exclude dividends.
This page exists because VRAX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.